Last 12 months
Inside the activity.
10 purchase rows · 139 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 4 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 26 |
| May 2026 | 0 | 54 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 5 | 44 |
| Aug 2026 | 1 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 18, 2026 01:43 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 8,972 | $36.99 | $331,874.28 |
DisclosureSEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 4 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,622 F4 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:43 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 4,465 | $36.00 | $160,740.00 |
DisclosureSEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 3 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 326,594 F4 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:43 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 7,845 | $37.04 | $290,578.80 |
DisclosureSEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 2 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 331,059 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.701 to $37.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:43 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 7,155 | $36.16 | $258,724.80 |
DisclosureSEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 1 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 338,904 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:46 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 90 | $37.54 | $3,378.60 |
DisclosureSEC source: 0001658918-26-000014 · form4-07182026_010744.xml · nonDerivative · entry 3 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,332,316 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:46 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 42,738 | $36.99 | $1,580,878.62 |
DisclosureSEC source: 0001658918-26-000014 · form4-07182026_010744.xml · nonDerivative · entry 2 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,332,406 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:46 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 18,950 | $36.00 | $682,200.00 |
DisclosureSEC source: 0001658918-26-000014 · form4-07182026_010744.xml · nonDerivative · entry 1 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,375,144 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:45 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 12 | $37.54 | $450.48 |
DisclosureSEC source: 0001728746-26-000012 · form4-07182026_010728.xml · nonDerivative · entry 3 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,086 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:45 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 5,393 | $36.99 | $199,487.07 |
DisclosureSEC source: 0001728746-26-000012 · form4-07182026_010728.xml · nonDerivative · entry 2 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,098 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:45 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 2,238 | $36.00 | $80,568.00 |
DisclosureSEC source: 0001728746-26-000012 · form4-07182026_010728.xml · nonDerivative · entry 1 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,491 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5251 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:44 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 10 | $37.54 | $375.40 |
DisclosureSEC source: 0001789970-26-000012 · form4-07182026_010724.xml · nonDerivative · entry 3 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,071 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:44 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 5,103 | $36.99 | $188,759.97 |
DisclosureSEC source: 0001789970-26-000012 · form4-07182026_010724.xml · nonDerivative · entry 2 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,081 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:44 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 2,147 | $36.00 | $77,292.00 |
DisclosureSEC source: 0001789970-26-000012 · form4-07182026_010724.xml · nonDerivative · entry 1 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,184 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 20, 2026 10:00 UTC |
Kreitzer AnatolChief Discovery Officer
|
SaleVoting Common Stock | 4,510 | $36.94 | $166,599.40 |
DisclosureSEC source: 0002021238-26-000010 · form4-07202026_060701.xml · nonDerivative · entry 2 Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,135 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.68 to $37.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 20, 2026 10:00 UTC |
Kreitzer AnatolChief Discovery Officer
|
SaleVoting Common Stock | 5,545 | $36.13 | $200,340.85 |
DisclosureSEC source: 0002021238-26-000010 · form4-07202026_060701.xml · nonDerivative · entry 1 Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,645 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 20, 2026 10:00 UTC |
GILLIS JONATHANCAO and Interim CFO
|
SaleVoting Common Stock | 4,699 | $36.94 | $173,581.06 |
DisclosureSEC source: 0001709954-26-000010 · form4-07202026_060704.xml · nonDerivative · entry 2 GILLIS JONATHAN · CIK 0001709954 · CAO and Interim CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,164 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.68 to $37.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 20, 2026 10:00 UTC |
GILLIS JONATHANCAO and Interim CFO
|
SaleVoting Common Stock | 5,356 | $36.13 | $193,512.28 |
DisclosureSEC source: 0001709954-26-000010 · form4-07202026_060704.xml · nonDerivative · entry 1 GILLIS JONATHAN · CIK 0001709954 · CAO and Interim CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,863 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:59 UTC |
Garnett Timothy JohnDirector
|
GrantStock Option (right to buy) · Derivative | 14,902 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001998937-26-000004 · form4-06252026_090607.xml · derivative · entry 3 Garnett Timothy John · CIK 0001998937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,902 Underlying: Voting Common Stock · 14,902 shares Expires 2036-06-22 F4 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:59 UTC |
Garnett Timothy JohnDirector
|
GrantVoting Common Stock | 3,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001998937-26-000004 · form4-06252026_090607.xml · nonDerivative · entry 1 Garnett Timothy John · CIK 0001998937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,457 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:57 UTC |
Luneborg Nanna LiebachDirector
|
GrantStock Option (right to buy) · Derivative | 14,902 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0002089511-26-000002 · form4-06252026_090604.xml · derivative · entry 2 Luneborg Nanna Liebach · CIK 0002089511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,902 Underlying: Voting Common Stock · 14,902 shares Expires 2036-06-22 F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:57 UTC |
Luneborg Nanna LiebachDirector
|
GrantVoting Common Stock | 3,932 | $0.00 | $0.00 |
DisclosureSEC source: 0002089511-26-000002 · form4-06252026_090604.xml · nonDerivative · entry 1 Luneborg Nanna Liebach · CIK 0002089511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,932 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:54 UTC |
Pavlov GeorgeDirector
|
GrantStock Option (right to buy) · Derivative | 14,902 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001470798-26-000004 · form4-06252026_090639.xml · derivative · entry 2 Pavlov George · CIK 0001470798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,902 Underlying: Voting Common Stock · 14,902 shares Expires 2036-06-22 F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:54 UTC |
Pavlov GeorgeDirector
|
GrantVoting Common Stock | 3,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001470798-26-000004 · form4-06252026_090639.xml · nonDerivative · entry 1 Pavlov George · CIK 0001470798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,932 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:01 UTC |
Babler MartinDirector
|
GrantStock Option (right to buy) · Derivative | 29,804 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001435618-26-000011 · form4-06252026_100631.xml · derivative · entry 2 Babler Martin · CIK 0001435618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,804 Underlying: Voting Common Stock · 29,804 shares Expires 2036-06-22 F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:01 UTC |
Babler MartinDirector
|
GrantVoting Common Stock | 7,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001435618-26-000011 · form4-06252026_100631.xml · nonDerivative · entry 1 Babler Martin · CIK 0001435618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,864 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:04 UTC |
Cox TroyDirector
|
GrantStock Option (right to buy) · Derivative | 29,804 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001696923-26-000005 · form4-06252026_100620.xml · derivative · entry 2 Cox Troy · CIK 0001696923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,804 Underlying: Voting Common Stock · 29,804 shares Expires 2036-06-22 F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:04 UTC |
Cox TroyDirector
|
GrantVoting Common Stock | 7,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001696923-26-000005 · form4-06252026_100620.xml · nonDerivative · entry 1 Cox Troy · CIK 0001696923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,864 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:52 UTC |
Walker Maria CDirector
|
GrantStock Option (right to buy) · Derivative | 14,902 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001826519-26-000002 · form4-06252026_090603.xml · derivative · entry 2 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,902 Underlying: Voting Common Stock · 14,902 shares Expires 2036-06-22 F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:52 UTC |
Walker Maria CDirector
|
GrantVoting Common Stock | 3,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001826519-26-000002 · form4-06252026_090603.xml · nonDerivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,703 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| May 18, 2026 Filed May 19, 2026 01:27 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 198 | $28.15 | $5,573.70 |
DisclosureSEC source: 0001658918-26-000012 · form4-05192026_010517.xml · nonDerivative · entry 2 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,394,094 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.57 to $28.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 18, 2026 Filed May 19, 2026 01:27 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 118,037 | $27.19 | $3,209,426.03 |
DisclosureSEC source: 0001658918-26-000012 · form4-05192026_010517.xml · nonDerivative · entry 1 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,394,292 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.565 to $27.4347 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 5,890 | $30.56 | $179,998.40 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 9 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,512,329 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.305 to $30.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 6,871 | $30.04 | $206,404.84 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 8 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,518,219 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.305 to $30.3045 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 877 | $28.70 | $25,169.90 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 7 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,525,090 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.183 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 342 | $27.57 | $9,428.94 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 6 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,525,967 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 5,808 | $30.56 | $177,492.48 |
DisclosureSEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 4 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,331 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.305 to $30.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 6,979 | $30.04 | $209,649.16 |
DisclosureSEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 3 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,139 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.305 to $30.2965 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 846 | $28.70 | $24,280.20 |
DisclosureSEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 2 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,118 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.183 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:30 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 284 | $27.61 | $7,841.24 |
DisclosureSEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 1 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,964 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 3,205 | $29.20 | $93,586.00 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 5 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,526,309 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.12 to $29.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 1,582 | $28.56 | $45,181.92 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 4 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,529,514 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.11 to $29.09 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 29,624 | $27.48 | $814,067.52 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 3 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,531,096 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.11 to $28.1099 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:30 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 117 | $29.10 | $3,404.70 |
DisclosureSEC source: 0002021233-26-000010 · form4-05112026_090503.xml · nonDerivative · entry 2 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,059 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.09 to $29.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:30 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 4,321 | $28.52 | $123,234.92 |
DisclosureSEC source: 0002021233-26-000010 · form4-05112026_090503.xml · nonDerivative · entry 1 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,176 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $29.045 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 5,220 | $29.15 | $152,163.00 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 2 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,560,720 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.91 to $29.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:30 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 14,880 | $28.47 | $423,633.60 |
DisclosureSEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 1 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,565,940 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.885 to $28.8833 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:30 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 721 | $28.28 | $20,389.88 |
DisclosureSEC source: 0001728746-26-000010 · form4-05112026_090501.xml · nonDerivative · entry 1 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 242,729 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $28.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 2,068 | $29.07 | $60,116.76 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 8 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 356,256 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.73 to $29.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 8,496 | $28.04 | $238,227.84 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 7 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 358,324 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.675 to $28.6587 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 15,900 | $29.13 | $463,167.00 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 8 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350,497 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.71 to $29.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.